Pieter Cullis
For their pioneering work developing nucleoside-modified mRNA and lipid nanoparticle (LNP) drug delivery: the foundational technologies for the highly effective COVID-19 mRNA vaccines.
Affilié au moment de l'attribution du prix
Université de la Colombie-Britannique
Vancouver, Canada